Tower Research Capital (TRC)’s Ambit Biosciences Corp AMBI Stock Holding History

Tower Research Capital (TRC)’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-516	Closed	-$8K	–	5448
2014 Q3	$8K	Sell	516 -2,002	-80%	-$13.8K	﹤0.01%	3044
2014 Q2	$18K	Buy	2,518 +2,294	+1,024%	+$16.1K	﹤0.01%	1926
2014 Q1	$2K	Sell	224 -1,376	-86%	-$14.6K	﹤0.01%	4036
2013 Q4	$15K	Buy	1,600 +381	+31%	+$5.09K	﹤0.01%	2651
2013 Q3	$19K	Sell	1,219 -2,925	-71%	-$38.8K	﹤0.01%	2753
2013 Q2	$29K	Buy	+4,144	New	+$29.6K	﹤0.01%	1387

Tower Research Capital (TRC)'s AMBI Position: Q4 2014 in Review

Tower Research Capital (TRC) sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 516 shares — an estimated $8K sold.

Tower Research Capital (TRC) first reported a position in AMBI in Q2 2013 and held it in 6 quarters. The position peaked at $29K in Q2 2013. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

Tower Research Capital (TRC) reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
Tower Research Capital (TRC) sold 516 Ambit Biosciences Corp shares in Q4 2014, an estimated $8K.
Tower Research Capital (TRC) first reported a position in Ambit Biosciences Corp in Q2 2013 and held it in 6 quarters.
Tower Research Capital (TRC)'s Ambit Biosciences Corp position peaked at $29K in Q2 2013.
0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2014, filed 5 Feb 2015.